AstraZeneca widens cancer push with up to $500 mln Heptares deal
 

AstraZeneca widens cancer push with up to $500 mln Heptares deal
LONDON, Aug 6 (Reuters) - AstraZeneca expanded its push into cancer immu**therapy on Thursday by striking a deal potentially worth more than $500 million with Sosei's biotech unit Heptares, giving it rights to an experimental treatment.
http://i1.wp.com/reuters.us.feedspor...f?resize=1%2C1 http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...Ag:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...Ag:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/xTzaD4B5sXk